IP Verse

High-Stability Packaged Solutions Of T4 Thyroid Hormone - EP3528847

The patent EP3528847 was granted to Altergon on Jul 22, 2020. The application was originally filed on Oct 17, 2017 under application number EP17794903A. The patent is currently recorded with a legal status of "Revoked".

EP3528847

ALTERGON
Application Number
EP17794903A
Filing Date
Oct 17, 2017
Status
Revoked
Mar 11, 2025
Grant Date
Jul 22, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

UNI PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIESApr 21, 2021SONNENHAUSERADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO2010086030
DESCRIPTIONWO2013072304
INTERNATIONAL-SEARCH-REPORTUS9345772
INTERNATIONAL-SEARCH-REPORTWO2012120338
INTERNATIONAL-SEARCH-REPORTWO2013072304
OPPOSITIONEP2683361
OPPOSITIONWO2013072304
OPPOSITIONWO2016137969
OTHERWO2013072304

Non-Patent Literature (NPL) Citations (13) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
INTERNATIONAL-SEARCH-REPORT- BOULTON D.W., FAWCETT J.P., WOODS D.J., "Stability of an extemporaneously compounded levothyroxine sodium oral liquid", AM J HEALTH-SYST PHARM, (19960515), vol. 53, pages 1157 - 1161, XP055294292 [Y] 1-13 * page 1161 *-
OPPOSITION- Anonymous, "Eltroxin 100micrograms per 5ml Oral Solution", Amdipharm Mercury Company, (20130101), Amdipharm Mercury Company, (20220920), XP055962590-
OPPOSITION- Anonymous, "Glass containers for pharmaceutical use", EUROPEAN PHARMACOPOEIA 7.0, (20100101), vol. 7, XP055962611-
OPPOSITION- Anonymous, "Mercury Pharma announces the launch of Eltroxin® (Levothyroxine) Oral Solution in a range of three strengths", Amdipharm Mercury, (20120529), Amdipharm Mercury, URL: http://www.mercurypharma.com/news/mercury-pharma-announces-the-launch-eltroxin-levothyroxine, (20220920), XP055962594-
OPPOSITION- BOULTON et al., "Stability of an extemporaneously compounded levothyroxine sodium oral liquid", Am J Health-Syst Pharm, (19960000), vol. 53, pages 1157 - 1161, XP055294292-
OPPOSITION- Dixon, Et Al., "Packaging materials: 9. multilayer packaging for food and beverages", ILSI Europe, (20110701), page 23, ILSI Europe, (20220322), XP055904028-
OPPOSITION- GLASS et al., "Stability considerations in liquid dosage forms extemporaneously prepared from commercially available products", J Pharm Pharmaceut Sci, (20060000), vol. 9, no. 3, pages 398 - 426, XP055241020-
OPPOSITION- Pharma Advanz, "Eltroxin 100micrograms per 5ml Oral Solution", EMC, (20130904), EMC, URL: https://www.medicines.org.uk/emc/medicine/27008, (20220920), XP055962592-
OPPOSITION- Thanassis Archondikis, "Statement regarding the stability studies of Levothyroxine solutions", UNI PHARMA, (20210407), UNI PHARMA, (20220920), XP055962599-
OPPOSITION- J. Lange, Yves Wyser, "Recent innovations in barrier technologies for plastic packaging?a review", Packaging Technology and Science, John Wiley & Sons, Ltd., (20030701), vol. 16, no. 4, doi:10.1002/pts.621, ISSN 08943214, pages 149 - 158, XP055119963
OPPOSITION- WON, "Kinetics of Degradation of Levothyroxine in Aqueous Solution and in Solid State", Pharmaceutical Research, (19920000), vol. 9, no. 1, doi:10.1023/A:1018952415732, XP009156943
OTHER- BOULTON D.W., FAWCETT J.P., WOODS D.J., "Stability of an extemporaneously compounded levothyroxine sodium oral liquid", Am. J. Health-Syst Pharm., (19960000), vol. 53, pages 1157 - 1161, XP055294292-
OTHER- "Chapter 6 - Commodity Thermoplastics: Polyvinyl Chloride, Polyolefins and Polystyrene", Vinni R. Sastri, Plastics in Medical Devices, (2014), pages 73 - 120, XP055605520-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents